1. The action of tubocurarine on voltage-clamped frog muscle end-plates has been re-examined by means of (a) equilibrium dose-ratio 
INTRODUCTION
The action of tubocurarine on the post-synaptic membrane of the neuromuscular junction has been considered to be one of the classical examples of competitive antagonism. The classical work of Jenkinson (1960) strongly suggested that the effect of tubocurarine could be accounted for entirely by competition with acetylcholine for the acetylcholine receptors on the post-synaptic membrane. On the other hand, the action of tubocurarine on Aplysia neurones appears to be quite different; the drug appears to work primarily by blocking ion channels while they are open, rather than by competing with acetylcholine (Marty, Neild & Ascher, 1976; Ascher, Marty & Neild, 1978) . Manalis (1977) observed that the effect of tubocurarine at the frog neuromuscular junction was dependent on membrane potential when the agonist was applied by ionophoresis, but not when it was applied by nerve stimulation, and he suggested that this effect might be the result of block of ion channels, of the sort seen in Aplysia.
We have investigated this problem in the frog, Rana esculenta. The methods that have been used were designed to allow us to assess, in particular, the following aspects of the action of tubocurarine. (a) The importance, and dependence on membrane potential, of the competitive action of tubocurarine, for which purpose application of known agonist concentrations is important so that dose ratios can be measured. Therefore agonist was applied in to the tissue bath (rather than by ionophoresis) in most experiments. (b) The rates, and their dependence on membrane potential, of the actions of tubocurarine. For this purpose it is necessary to use voltage-clamped end-plates, and kinetic measurements were made by both noise analysis, and by means of voltage-jump relaxations. Two kinetic components were clearly seen in the presence of agonist and tubocurarine by the voltage-jump method, but the slower component was too slow to be resolved by the noise method.
Some of the results in this paper have already been communicated to the Physiological Society (Colquhoun, Dreyer & Sheridan, 1978) .
METHODS
Experiments were performed on the cutaneus pectoris muscle of the frog (Rana esculenta unless otherwise noted). The preparation was pinned to a thin layer of Sylgard (Dow-Corning) on the glass (microscope slide) base of a Perspex tissue bath. The muscle was continuously perfused with Ringer solution through a glass pipette (2 mm i.d. shank with a wide flattened end which was placed as close as possible to the impaled end-plate). This pipette was also used to apply drug solutions (cf. Cooke & Quastel, 1973) . Unless otherwise stated, the Ringer solution contained (mM) NaCl 117, KCl 2-5, CaCl2 1.0, MgCl2 1-8, Na3PO4 buffer 2-0 and 100 nM-tetrodotoxin (Sigma Chemical Co.). The pH of this solution was 7-0-7-1. The inflowing solution was cooled by means of a jacketed tube through which cold water was circulated, and the tissue bath had a tube around its periphery through which cold water also flowed. The flow rate of solution was about 3 ml./min, and the temperature, which was routinely measured with a thermistor bead placed as close to the recording site as possible, was 8*5-9.5 TC unless otherwise stated. Carbachol was obtained from Aldrich Chemical Co. Inc. and (+ )-tubocurarine, B.P., from Koch-Light Labs. or Sigma Chemical Company. Purified a-bungarotoxin was kindly given to us by Professor E. A. Barnard; a solution of 50 or 100 nM was perfused over the preparation until the desired degree of block was achieved, and then washed out with Ringer solution.
Recording of end-plate currents. End-plates were located visually by means of a Zeiss Nomarski differential interference contrast microscope with modified stage (Micro Instruments, Oxford).
Normally a 40 x water-immersion objective was used. The end-plate was penetrated with a voltage recording micro-electrode filled with 2-5-3 M-KCl (resistance 5-10 MO usually) and, close by, with a current recording electrode filled with 2 M-K citrate adjusted to pH 7 0 with citric acid (5-15 MO usually). The objective was then raised from the solution (mainly to aid temperature control) and the voltage clamp (similar to that of ) switched on. The size and rate of rise of miniature end-plate currents were used as an additional check on the location of the electrodes. The clamp gain, and the capacity compensation on the voltage follower, were adjusted by optimizing the response to a 5 mV rectangular command pulse.
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Noise measurements were made as described by Colquhoun, Large & Rang (1977) , except that the filtered signal was sometimes sampled on line by a PDP 11/40 computer. The computer also supplied command potentials for the voltage-jump experiments, each potential jump being followed by on-line sampling of the end-plate current, which was normally filtered above 2 or 3 kHz (Barr & Stroud EF3-02; 160 db/decade roll-off; damped mode). In most experiments the tissue bath was grounded directly via an Ag/AgCl wire electrode. In a few experiments the bath was clamped to ground potential by means of two Ag/AgCl (sintered) bath electrodes. One, used for voltage sensing, was connected to a voltage follower, so hardly any current flowed through it (thus avoiding polarization of the electrode), the follower output was inverted and fed back to the second bath electrode to maintain the bath at ground potential.
Both methods gave similar results which indicates that electrode polarization was not a serious problem.
Analysis of current fluctuations (noise). The noise signal was edited visually and sections that contained miniature end-plate currents, or other interference, were removed. The usuable noise data, between faults, were divided into as many sections as possible of length 1/fr8 seconds wheref,,. (Hz) was the desired resolution. From each section a power spectrum was calculated directly using a fast Fourier transform (uniform or 'boxcar' data window). The spectral densities calculated from the data were then averaged and the mean control spectrum (found from noise in the absence of agonist) was subtracted from the mean spectrum of noise observed in the presence of agonist. The net one-sided spectral density, G(f), s0 found was fitted by Lorentzian components of the form, G(f) = G(0)/[1+ (f /f")2], where f = frequency and fe = halfpower frequency. One such component, or the sum of several Lorentzians, was fitted by the method of weighted least-squares, using the Patternsearch method (see Colquhoun, 1971 Colquhoun, , 1978b .
The points in the net spectrum were weighted in the following way. Say Gd(f) and G((f) are the mean spectral densities, at frequency, in the presence and absence (control), respectively, of the drug. Thus the net spectral density is G(f) = Gd(f) -Gc(f). The spectral estimates are distributed approximately as X2/2 (see for example, Bendat & Piersol, 1971 ) so they have a constant coefficient of variation of 1(2/n), where n is the number of degrees of freedom of the spectral estimate. The spectrum is fitted to the log1o G(f) values, so if G" and Gd are independent, the weight, w(f), for each such value (i.e. the reciprocal of its variance) will be, approximately, w(f) 2-3032nd (x -1)2 2 (X +y)' where x = Gd(f)/Gc(f), y = nd/nC, and nd, nc are the number of spectra averaged to get the mean spectrum with and without agonist present, respectively. Thus the weight will approach a maximum constant value, 2-3032nd/2, when the control spectral density is far below that in the presence of agonist (x large), and will fall to zero as Gd approaches G,. In practice weights were smoothed by averaging in groups (usually of eight frequency points) to avoid excessive fluctuation of the weights from point to point. The same weights were used to calculate approximate standard errors for the fitted parameters from the inverse Hessian matrix, as described by Colquhoun, Rang & Ritchie (1974) .
The apparent single channel conductance, ypp, was estimated as ypp = var (I)/m1(V-I.).
In this expression var (I) is the variance of the drug-induced current calculated as the difference between the directly calculated variances of the edited noise in the presence and absence of the agonist, m, is the mean drug-induced current, V is the membrane potential and K q the equilibrium potential (taken as zero: see Results). This value was corrected for loss of variance at frequencies below Am and above fmax, the frequencies at which the observed noise was filtered.
Suppose the spectrum is fitted by the sum of k Lorentzian components, the ith component being denoted Gi(f) and having half-power frequency fc"). Then the fraction of the total variance between fmin and fmax will be Colquhoun, 1978a) . Analysis of relaxations. The sampling rate of the analogue to digital convertor was, when convenient, set to be faster for the earlier points following the voltage jump than for later points. This enabled both fast and slow relaxations to be resolved in a single jump. The membrane current obtained by performing the voltage jump in the absence of agonist (immediately before or after agonist application) was subtracted from that obtained by imposing the same jump in the presence of agonist, to obtain the net current flowing through channels opened by the agonist. All currents illustrated, or referred to, in this paper are net currents found in this way.
An exponential, or sum of exponential, was fitted to the net current by equally weighted least squares. The asymptote was estimated along with the other parameters, rather than being guessed beforehand. When necessary (see Results) a sloping base line was fitted too. The early capacitative transient, and occasionally other undesired points, were assessed visually and omitted from the fitting process. Approximate standard errors were found as above, except that all weights were set to 1-0 and the diagonal elements of the inverted Hessian were multiplied by an estimate of experimental variance found from the scatter of points about the fitted line, viz. Smnin/(N -p), where Smin is the minimum sum of squared deviations, N is the number of points fitted and p is the number of parameters fitted. Some of the problems of fitting exponentials are discussed by Colquhoun (1978b) .
When the reversal potential was estimated from instantaneous current-voltage plots (e.g. Fig. 6A ) of jumps from a series of hyperpolarized membrane potentials, back to the holding potential, it was sometimes found that, the estimate of the reversal potential was negatively correlated with the estimate of the time constant at the holding potential. This arose because the estimate of the time constant was often correlated negatively with the amplitude of the relaxation. Therefore those relaxations that gave a time constant that was too fast, also gave an estimate of instaneous current that was too negative. As a result of this phenomenon it was occasionally found desirable to estimate the instantaneous current, before fitting the relaxation, by taking the reversal potential as zero (see Results), and constraining the fit to go through this estimated instantaneous (zero time) current. The constraint was achieved by adding a penalty factor to the sum of squared deviations: this factor was a constant (usually 10 or 20) times the absolute value of the difference between the desired zero time current, and the calculated zero time current.
RESULTS

Experiments at equilibrium Equilibrium responses and desensitization
Application of a moderate carbachol concentration (sufficient to produce an inward current of up to 40 or 50 nA), usually resulted in a stable plateau which was maintained for the duration of the application (not usually more than a minute or so). Such responses are illustrated in Fig. 1 (A 1 at -70 mV and B1 at -120 mV). It is quite likely that some desensitization was present during the plateau because it was often observed that the amplitude of miniature end-plate currents was reduced. This was not investigated in detail. At higher agonist concentrations, a slow decline in the response was seen and this will be referred to as desensitization. Densitization was found to be a good deal more prominent with acetylcholine than with carbachol, so the latter agonist was used in most experiments.
In the presence of tubocurarine, with agonist concentration raised so as to keep the response similar to that before addition of tubocurarine, desensitization was rather faster than in its absence, but slower than the desensitization rate that the raised agonist concentration would have produced without tubocurarine (see Fig. 12 ). The desensitization rate increased with agonist concentration (for a given tubocurarine concentration) as shown in Fig. 1 (A2 and A3 at -70 mV; B2-B4 at -120 mV). If the response was small enough there was no obvious desensitization even in the presence of tubocurarine. The decline is more or less linear in Fig. 1 (A 1-B3 Adams (1975) and, in electric eel, by Lester, Changeux & Sheridan (1975 1959; see also Thron, 1973 and Colquhoun, 1973) is to measure the shift of the equilibrium response vs. log agonist concentration curve that is produced by various concentrations of antagonist. In the case of a pure competitive antagonist, it is predicted, for a wide range of theories of agonist action, that the dose ratio, r (the factor by which agonist concentration must be increased to maintain a constant response in the presence of antagonist) will be given by the Schild equation
The normalized concentration, CB, of the antagonist (B) is defined as
where XB is the concentration of antagonist and KB its equilibrium (dissociation) constant. Fig. 2A shows an example of the dose-response curves determined under our conditions, with the end-plate clamped at -70 mV. The effect of tubocurarine was completely reversible, as shown by complete recovery of the control curve after removal of tubocurarine. The dashed lines in Fig. 2A show the parallel shifts predicted by eqn. (1) (taking KB = 027 JtM, see below). The observations are quite close to these predictions (except for the response at the higher agonist concentration in 5 /LM-tubocurarine; this was a consistent finding which is discussed below). Fig. 2B shows dose-response curves determined in the same way, except that the end-plate was clamped at -120 mV. As at -70 mV, the effect of tubocurarine was completely reversible, and, as at -70 mV, the effect of the lowest tubocurarine concentration (0.3 ,uM) was close to that predicted for competitive antagonism (with KB = 0*27 /,M as at -70 mV). However, above this tubocurarine concentration, increasingly large deviations from the competitive prediction were seen at -120 mV. The size of the deviations increases with agonist concentration (they are greater at the higher than at the lower concentration for any given tubocurarine concentration) as well as with tubocurarine concentration. And the deviations from competitive behaviour clearly increase as the end-plate is hyperpolarized.
The dose ratios (r) measured from Fig. 2 (at the arbitrarily chosen response levels specified therein) are plotted in Fig. 3 , as log (r -1) vs. log xB. For a pure competitive antagonist the logarithmic form of eqns. (1) and (2), log (r-1) = log XB-log KB, (3) predicts that such a plot should be linear, with unit slope, and that the intercept on the abscissa at r -1 = 1 is an estimate of log KB. It can be seen that, at -70 mV, tubocurarine behaves like a competitive inhibitor. The point for 5 guM-tubocurarine lies above the line, but a crude correction for 'desensitization' by extrapolation of the response, such as that shown in Fig. 1 (A 3) , to zero time suggests that this deviation may be mainly the result of desensitization rather than non-competitive behaviour (see Discussion).
On the other hand, at -120 mV, a considerable deviation from simple competitive behaviour is seen in Fig. 3 , as expected from Fig. 2 *, dose ratios from equilibrium current at -70 mV (from Fig. 2) . A, dose ratios from equilibrium current at -120 mV (from Fig. 2) . A, dose ratios from peak current at -120 mV (same experiment as Fig. 2 ; see text).
in Fig. 3 appear to converge, so the slope, even at -120 mV, approaches unity, and the estimates of KB obtained from this graph are virtually identical, viz. 0-27,uM, at both -70 and at -120mV.
Dose-response curves, such as those shown in Fig. 2 , can also be plotted not with the equilibrium responses, but with the peak responses (i.e. the currents observed before the slow inverse relaxation has had any important effect, see Fig. 5 and p. 257). If dose ratios are measured from such curves, despite the fact that the responses are not at equilibrium, the antagonist behaves as though it were competitive even at hyperpolarized membrane potentials. For example in Fig. 3 , the dose ratios measured from peak currents at -120 mV show virtually the same competitive behaviour as those measured at -70 mV, although the equilibrium dose ratios at -120 mV deviate considerably from simple competitive behaviour.
The obvious, but not the only, interpretation of the results shown in Figs. 2 and 3 is that tubocurarine is mainly a simple competitive antagonist at -70 mV, but, as the end-plate is hyperpolarized, a voltage-dependent, non-competitive form of ACTIONS OF TUBOCURARINE block appears in addition to the competitive action. According to this interpretation, Fig. 3 Voltage-dependent effect at equilibrium (3,uM) . As the membrane is hyperpolarized, the driving potential increases and, normally, more channels open too, so the equilibrium current increases more than in proportion to the hyperpolarization, as shown later (see p. 258 and dashed line in Fig. 6A ; the filled circles in Fig. 4 behave similarly and this will be discussed later). However, in the presence of tubocurarine it is seen that, although moderate hyperpolarization caused an increase in current, the curvature was in the opposite direction to usual, and eventually, further hyperpolarization actually caused a decrease in current, despite the continued increase in driving force. This observation is qualitatively similar to the anomalous voltagedependence of inward current, in the presence of tubocurarine, observed by Manalis (1977) during prolonged application of acetylcholine by ionophoresis.
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The single channel conductance The mean single channel conductance, measured as described in Methods, was y = 20-5 + 1*5 pS (6) at -70 or -80 mV in the absence of tubocurarine. This is slightly lower than the value of 25 pS reported by Colquhoun, Dionne, Steinbach & Stevens (1975) , possibly because of the presence of magnesium in our Ringer (B. Sakmann & P. R. Adams, personal communication). The mean ratio, in nine experiments, ofy in the presence of tubocurarine (1-5 /LM) to y in its absence was 0 95 + 0 03.
At hyperpolarized potentials (-120 or -140 mV) , at which the voltage-dependent block is more prominent, the ratio was 0*92 + 0*02 (4); and near the resting potential (-70 or -80 mV) the ratio was 0*98 + 0*04 (5). In eight experiments out of ten, some reduction of y by tubocurarine was observed (P = 0-11, sign test). Thus there is a hint of slight reduction of 'y by tubocurarine at negative membrane potentials, but if real it is certainly small, and it cannot be regarded as well established.
Kinetic experiments
The changes in kinetic measurements produced by tubocurarine
The rates of the reactions underlying the equilibrium responses that have been described, were measured by two methods: (a) by following the relaxation of the membrane current that follows a step change in membrane potential, and (b) by measuring current fluctuations at equilibrium. With the former method, two exponential components could be clearly resolved in the presence of tubocurarine. The faster one is similar to the normal rate constant seen in its absence. Its time constant is known to give, under certain circumstances, a good estimate of the mean open lifetime of the ion channels that are opened by the agonist (see Anderson & Stevens, 1973; Neher & Sakmann, 1975; Colquhoun & Hawkes, 1977) . The second component is very much slower. Noise analysis was used to measure the faster rate constant, but the slower one was much too slow to be resolved by this method.
The basic phenomenon that we have observed is illustrated in Fig. 5. It will be described briefly and qualitatively now; the details will be presented in subsequent sections.
Before zero time, in Fig. 5A the end-plate was held at -80 mV and the current through the channels opened by carbachol (10 /M) was about -20 nA. At time zero, the potential across the end-plate was stepped to -140 mV, there was an immediate ohmic jump in the current, to about -32 nA (the instantaneous current) as more current flowed through the channels that were already open, under the influence of the increased potential gradient. During the next 32 msec (which is shown on a greatly expanded time-scale), more channels open under the influence of the more hyperpolarized potential (Rang, 1973; . Eventually, the equilibrium current, about -90 nA, appropriate to -140 mV, was reached. The time constant for this re-equilibration (relaxation) is denoted rf. It is about 6-2 + 0-3 msec at -140 mV in Fig. 5A . Once the equilibrium current had been reached, it stayed more or less constant for the next 8 sec.
It will be noticed that there is a further increase in inward current between about 30 and 300 msec. This was frequently observed, and its time constant (in so far as it could be fitted 256 ACTIONS OF TUBOCURARINE by an exponential) was usually between 30 and 300 msec, probably rather too slow for it to be attributed to the opening of extrajunctional channels. It is, no doubt, the same phenomenon as the 'sloping base line' observed by Neher & Sakmann (1975) and by Adams (1977a) . They suggested that it might result from ionophoresis of agonist from the bulk solution into the synaptic cleft. This is one possibility, but the process seems rather slow for this mechanism. Another possibility is that it may result from slight movements caused by local contracture at the end-plate. The effect was usually reversible. The equilibrium current at -140 mV was taken as the asymptote of the first, major, exponential component. After 8032 msec, the membrane potential was stepped back to -80 mV, and there was again an ohmic jump in current. Then channels shut during the first 32 msec (rather faster than they opened) until the equilibrium current at -80 mV (-20 nA, as it was before the voltage jump) was reached again. The current then remained constant until the agonist was removed.
The results of imposing the same voltage jump in the presence of tubocurarine
(1-5 /tM) are shown in Fig. 5B . The agonist concentration was increased so as to produce a similar (peak) current to that in the absence of tubocurarine. Before zero time the current at -80 mV was about -23 nA. The fast relaxations were very similar to those in the absence of tubocurarine, except that they are slightly faster (e.g. Tf = 4-3 + 0-2 msec at -140 mV in Fig. 5B ) in the presence of tubocurarine. However, the peak current at -140 mV (about -95 nA) was not maintained, but waned slowly, until equilibrium at -140 mV was eventually reached at about -60 nA. The time constant for this slow inverse relaxation is denoted Tr (it is about 2 see in this example). When the potential was jumped back to -80 mV, after 8032 msec, the process reversed. After the rapid shutting of channels, the current reached a peak value of -18 nA, but then channels slowly opened again (with time constant denoted Ts; about 1-3 sec in Fig. 5 ) until the equilibrium current at -80 mV (-23 nA, as it was before the jump) was eventually reached.
9
PHY 293 257 D. COLQUHOUN, F. DREYER AND R. E. SHERIDAN
The reversal potential The voltage-jump method allowed rapid, though not particularly accurate, estimation of the reversal potential for the ion channels opened by carbachol. Fig. 6A shows the instantaneous current-voltage relationship in the presence of carbachol (15 ,aI) . The open symbols show the current flowing immediately before a jump, and the filled symbols show the ('instantaneous') current immediately after a step change to a new potential (found by extrapolation of the curve fitted to the ensuing relaxation back to the moment of the jump). The sort of experimental record from which this information was obtained is illustrated in Fig. 5 . The points immediately before and after the jump (separated by such a short time that the number of open channels does not have time to change) are joined, and this line can be extrapolated linearly to zero current. Individual ion channels behave ohmically over the observed range of potentials in agreement with Magleby & Stevens (1972b) as shown by the linearity in Fig. 6 . If they continue to behave ohmically at more depolarized potentials this procedure yields an estimate of the reversal potential, Vrev. In this example, rev was 3-8 + 2-7 mV (5), and, although there was considerable scatter in the estimates, Vrev did not usually differ significantly from zero, so this value was used for all calculations. After a step in the hyperpolarizing direction (upper curve in Fig. 6A ), ion channels opened, with time constant Tf, during the subsequent relaxation (see Fig. 5 ) until the current reached (or nearly reached, depending on the time allowed) a new equilibrium level at the hyperpolarized potential (open symbols on lower curves, Fig. 6 ). The dashed line drawn through the open symbols is, therefore, a close approximation to the equilibrium current-voltage relationship. The curvature of this relationship, seen in Fig. 6A , is now well known (Rang, 1973; Adams, 1976a; Mallart, Dreyer & Peper, 1976) .
It is necessary, for the analysis of our results, to know whether the reversal potential is affected by the presence of tubocurarine or by long hyperpolarizing jumps. The experiment on which the Fig. 6B is based involved 8032 msec hyperpolarizing jumps from a holding potential of -70 mV, in the presence of carbachol (150 pM) and tubocurarine (3 /tM). The set of instantaneous current-voltage curves look, in tubocurarine, more complicated than those without it in Fig. 6A , because of the large inverse relaxation (see Fig. 5B for example). The reversal potential, -0 95 + 5*4 mV (8) has not obviously changed from the value of zero assumed in the absence of tubocurarine, and was similar for jumps in the hyperpolarizing direction (-0 9 + 11 mV (4)) and for jumps in the depolarizing direction after 8032 msec hyperpolarization (-1 0 + 3-5 mV (4)). Since 8032 msec is long enough for equilibrium to be closely approached the dashed line in Fig. 6B is near to the equilibrium (Fig. 6A) , because of its voltage-dependent blocking action. On the other hand, it is worth noting that plotting, against voltage, the peak (rather than equilibrium) current in the presence of tubocurarine (e.g. the most negative current in Fig. 5B ) produces a curve (illustrated in Fig. 4 ) that is much more like the equilibrium curve in its absence (Fig. 6A) than that in its presence (Fig. 4 or Fig. 6B ). were seriously inadequate, one might expect that the voltage sensitivity of af would be spuriously low (Magleby & Stevens, 1972b) . In these experiments, in which the whole length of the end-plate was activated, it was therefore considered particularly important to check the voltage sensitivity of Tf.
The time constants, Tf, of the relaxation towards a new equilibrium current (see then Hf ,the potential change for an e-fold increase in rate, is 71 mV for the results in Fig. 7 . Similar values were found in other experiments, whether Tf was measured by the relaxation or by the noise method.
In twelve experiments, the average value of Hf was 78x7 + 1x9 mV in the absence 260 ACTIONS OF TUBOCURARINE of tubocurarine. The work of Anderson & Stevens (1973) , who applied agonist to a restricted (and therefore more readily clamped) area of the end-plate by ionophoresis, suggests that Hf should be 70-80 mV at the temperature (8-9 'C) of our experiments; our results are compatible with these values.
An example of the voltage dependence of Tf in the presence of tubocurarine (3 AM) is also shown in Fig. 7 (lower curve); it is from the same experiment that was shown in Fig. 6 . The voltage dependence of Tf is reduced by tubocurarine; a straight line through the lower curve yields an estimate of about 105 mV for Hf in the presence of tubocurarine. The line drawn through the lower curve in Fig. 7 was calculated from eqn. (5), taking k+iB = 2-7 x 107 M-1 sec'1 at -150 mV, and H+B =-59 mV. Fig. 7 shows that, at any given membrane potential, Tf gets faster when tubocurarine is present, especially at the more hyperpolarized potentials. This phenomenon is described in more detail below. Effect of tubocurarine on the fast relaxation It has usually been found, in the past, that tubocurarine has, at most, a small effect on acetylcholine channel lifetime, or on evoked end-plate current decay rate when cholinesterase is active (Beranek & Vyskocil, 1967; Katz & Miledi, 1972; Magleby & Stevens, 1972a) . But Takeuchi & Takeuchi (1959) mention an acceleration of the evoked end-plate current by tubocurarine, and Mallart & Molgo (1978) recently observed a larger effect. Near the normal resting potential, the effect of tubocurarine on rf is indeed small (Figs. 7 and 11) . But when the end-plate is hyperpolarized the effect becomes much more obvious. The voltage-jump experiment shown in Fig. 8 illustrates this phenomenon. In the presence of carbachol (6 ,M) alone, rf was 6*8 + 0 1 msec at -150 mV and 2-3 + 0-1 msec at -70 mV (Fig. 8A ).
After equilibration with tubocurarine (5 /M) and a raised carbachol concentration (130 AM) to maintain a similar peak response, 7-at -150 mV fell to 3-1 + 0-2 msec, 261 262 D. COLQUHOUN, F. DREYER AND R. E. SHERIDAN 46 % of its value is the absence of tubocurarine, but Tf at -70 mV (1I8 + 0 3 msec) fell much less (Fig. 8B) .
A similar acceleration of the fast kinetic component was seen in noise experiments. In Fig. 9 , the net spectrum of current fluctuations produced by 6 ,uM-carbachol at a membrane potential of -120 mV is close to a single Lorentzian with a halfpower frequency, f, of 49 4 + 1-8 Hz (i.e. -r = 1/27Tfc = 3*2 msec). However in the presence of 3,uM-tubocurarine (and a tenfold higher carbachol concentration to maintain the response) the spectrum (Fig. 9 , open circles) had a higher half-power frequency, fc = 65*6 + 2*3 Hz (i.e. af = 2-4 msec), 33 % faster than in the absence of tubocurarine.
It might be objected that the changed rates reflected the increased agonist concentration rather than the presence of tubocurarine, but (qualitatively at leastsee discussion) this is not so for the following reasons. (a) The decrease in rf observed when carbachol concentrations near 130 /M were tested, in the absence of tubocurarine (after BuTX treatment), were much smaller than the effect shown in Fig. 8A and B (see above). (b) The effect of tubocurarine on Tr can be observed even when the agonist concentration is held constant, though not easily because any concentration of tubocurarine that is large enough to have a substantial effect on T7 reduces the current so much that precise measurement is difficult. An example is shown in Fig. 8C and D the decay phase of the nerve-evoked end-plate current. The time constant of this decay is a good measure of rf (Katz & Miledi, 1972; Anderson & Stevens, 1973) , and, because the agonist concentration is near zero during most of the decay phase, the effect of tubocurarine on 'f cannot be attributed to high agonist concentration.
An example of this effect is shown in Fig. 10 ; at -140 mV the time constant for the decay phase is 6-1 msec, but in 3 /iM-tubocurarine it is reduced to 3*6 msec.
Measurements of this sort have been exploited by Katz & Miledi (1978) in their recent study.
The effect of the tubocurarine concentration on the fast relaxation rate constant, Tj-1, in one experiment is plotted in Fig. 11 . The lines are straight, within experimental error, and, as suggested by the results in Fig. 7 , the slope (change in T1 per unit increment in tubocurarine concentration) increases as the end-plate is hyperpolarized. It will be shown later (p. 271) that the slope of the lines in Fig. 11 depends exponentially on voltage, and the average size of the effect will be discussed there. There is a decrease of inward current during the hyperpolarizing step, even in the absence of tubocurarine, and its amplitude increases with carbachol concentration. It is quite slow, T8 = 11.2+2-45 sec for 100 #M-carbachol (Fig. 12A ) and rs = 9-5 + 0-5 sec for 200 tM-carbachol (Fig. 12C) . These rates are rather faster than the desensitization time constant of at least 40 see described earlier (see Fig. 1 , Al, B1), presumably because of the higher carbachol concentrations used in Figs. 12A and C. These, and similar measurements of slow relaxations in the absence of tubocurarine, are plotted in Fig. 14 (lower curve) .
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When a low concentration of tubocurarine (0.4 /IM in Fig. 12 ) is added, without increasing the agonist concentration, clear inverse relaxations appeared ( Fig. 12B  and D) , both at -120 and at -70 mV. At -120 mV, the time constants for these relaxations were 2-5 + 0-45 sec (Fig. 12B ) and 1-25 + 0.065 sec (Fig. 12D ). These are a good deal faster than in the absence of tubocurarine, so, even if it did not reduce the desensitization rate for a fixed agonist concentration, which it probably does (see Figs. 1 and 12) , the measurement of T5 should not be grossly distorted.
Measurements of r5 at various tubocurarine and agonist concentrations are shown in Fig. 13 , for two membrane potentials. In these experiments the muscle had not been treated with BuTX. At -70 mV, Ts was around 1 sec, as was usually observed, and it did not noticeably depend (over the range shown) on either tubocurarine or carbachol concentration. At -120 mV, Tr was slower (as can be seen in
Figs. 5B, 12B and D), about 3 see; and a slight increase in rate with both substances may be suspected from the results in Fig. 13 . The dependence of Ts on agonist concentration can be tested over a much wider range if the muscle is progressively treated with BuTX to maintain a reasonable response size. The results from several such experiments are shown in Fig. 14 . The tubocurarine concentration was small, and constant throughout (approximately: see legend). The slow inverse relaxation rate, T 1 is seen to change little up to about 100 /tM-carbachol, but further increases in agonist concentration caused a substantial increase in rate (see later, pp. 268, 274, for discussion of this observation). The rate is always a good deal faster than that observed in the absence of tubocurarine (lower curve). In a few experiments, voltage jumps were not performed until the desensitization (as illustrated in Fig. 1A Interpretation of the observations Only one interpretation of the observations in terms of mechanism has been attempted so far. It was suggested that affinity constants could be extracted from Schild plots of equilibrium observations (e.g. Fig. 3 ) even when, as at hyperpolarized potentials, they are curved. The hypothesis on which this is based is that a separate process, which is independent of competitive inhibition, supervenes at the higher tubocurarine concentrations and more negative membrane potentials, to cause the curvature. Our results are compatible with this hypothesis but do not prove it.
The interpretation of the equilibrium and kinetic observations will now be discussed. The most economical hypotheses are as follows.
(1) Voltage-dependent competitive binding If binding of tubocurarine to the acetylcholine receptor increased sufficiently with hyperpolarization, the inverse relaxations would be expected, as would the shape of the equilibrium current-voltage relationship shown in Fig. 4 (Fig. 3) . It is therefore, unlikely that either of the rate constants, k+B or klB is strongly voltage dependent. (b) Such a mechanism cannot simply explain the increase in Tr1 produced by tubocurarine. (c) It cannot explain the steep increase of r;1 with agonist concentation (see Fig. 14 Manalis, 1977) .
(2) Effects of agonist concentration and desensitization
The decrease in Tr produced by tubocurarine might be a result of increased agonist concentration. Reasons for thinking that this is not correct, or at least not the only mechanism, have already been presented (p. 262). The slow inverse relaxation produced by tubocurarine might be a result of an enhancement of desensitization by tubocurarine. But desensitization in the presence of tubocurarine, as judged by the results in Fig. 1 , is still quite slow, so it would be necessary to postulate the appearance of a second, much faster, component of desensitization in the presence of the drug. This is rather arbitrary, and also begs the question of the mechanism by which such a component might be produced.
(3) Current carries tubocurarine into the synaptic cleft
The current that flows into the synaptic cleft, to hold the end-plate at a fixed potential must, to some extent, be carried by tubocurarine, and by carbachol. This effect, and others that involve changes in the drug concentration in the cleft (see Discussion), could well be important because of the small volume of the cleft.
The sort of numerical values assumed in this section, and in the Appendix, imply that when the tissue has equilibrated with 03 ItM-tubocurarine, so that about half the binding sites are occupied by tubocurarine, there will be only one free molecule in the cleft for every 50 or more tubocurarine molecules that are bound to acetylcholine receptors. The work of Castillo & Katz (1957) suggests that tubocurarine diffuses slowly, with a time constant of the order of a second. When the end-plate is hyperpolarized, more inward current flows, and more tubocurarine will enter, thus causing channels to shut slowly; i.e. causing a slow inverse relaxation even if tubocurarine binding were purely competitive and not voltage-dependent. Furthermore, the rate and extent of this slow inverse relaxation would be expected to increase with agonist concentration (because of the larger inward current). And the rate should be increased by raising the tubocurarine concentration or by BuTX treatment, both of which should increase the diffusion rate of tubocurarine in the (-20 to -30 nA at -70 mV for example) and the time constant for diffusion in the absence of binding, r0, was taken, rather conservatively, as 10 msec for tubocurarine, which, in the absence of binding, would be expected to diffuse only slightly more slowly than acetylcholine. Other numerical values are specified in the Appendix. Very similar results were found, with far less trouble, by the use of eqns. (A 7) and (A 9). The expected characteristics, mentioned above, of the slow relaxation caused by ionophoresis of tubocurarine into the cleft were predicted by these calculations.
The predicted amplitude of the inverse relaxations was quite small; for CB = 1-20 (e.g. 0*3-6/tM-tubocurarine) they were 0*5-1-5nA at -70mV, and 2-4nA at -120 mV. This is considerably smaller than is actually observed. However, it is only just negligible, and it must be remembered that the method of calculation is rather simple-minded. The time constant predicted at -120 mV for CB = 1 (e.g. 0*3 /sM-tubocurarine) is about 280 msec, i.e. roughly 10 times faster than is actually observed. The predicted rate always increased slightly with hyperpolarization, quite contrary to the experimental observations. And, perhaps most striking, the time constant for the slow inverse relaxation is predicted to fall sharply with antagonist concentration, from 300 msec at CB = 1 (e.g. 0 3 ,tM-tubocurarine), to 42 msec at GB = 5 (e.g. 1*5 /LM), and to 13 mseat t cB = 20 (e.g. 6 /SM). This contrasts strongly with the very modest concentration dependence of the slow relaxation that is actually observed (see Fig. 13 ). Similar arguments can be applied to the ionophoresis of agonist into the synaptic cleft. It would appear (e.g. from eqn. (A 2)) that the relative agonist concentrations, at equilibrium, in the cleft and in the bulk solution should be affected by ionophoretic flux of agonist to a similar extent to that predicted for tubocurarine. The fact that no evidence exists for the importance of this effect with agonist (e.g. is another indirect reason for thinking that it may not be a large effect with antagonists either. Furthermore, the effects of agonist and antagonist influx would be expected to cancel each other, though not exactly. It has been suggested (Adams, 1977a ) that ionophoretic flux of agonist into the cleft might produce the 'sloping baseline' effect that we also see (see p. 256 known cooperativity of the response to agonist, and (b) it ignores the possibility that the blocking agent may bind to the ion channel (as opposed to the agonist receptor) even when the channel is in its shut conformation (see para. 5, below). But the scheme is relatively simple, so it seems worth discussing the extent to which it can explain our observations before trying to take into account the complications of cooperativity and so on. The predictions of scheme 4 will now be considered briefly. They are discussed in greater detail elsewhere (D. Colquhoun, in preparation) . If the binding of agonist is assumed to be fast (this is not known for certain; e.g. Anderson & Stevens, 1973) then there are four kinetically distinguishable states in scheme (4), so there should be three kinetic components, the rate constants of which can be calculated as discussed, for example, by Colquhoun & Hawkes (1977) . In fact we have never been able consistently to measure more than two rate constants, rT1 and r;1. However, this is not entirely surprising: it can be shown (D. Colquhoun, in preparation) for that a pure competitive antagonist (state ARB omitted from scheme 4), although two kinetic components are predicted, one of them usually, under conditions like those in our experiments, has such a low amplitude that it would be unlikely to be detected in experiments (except, for example, when it has a rate close to a and would therefore be difficult to measure). Similar behaviour is predicted for scheme 4; under most conditions only two of the three components are likely to be detected. At sufficiently low concentrations of agonist we would expect that T 1 a+k+BxB, (5) where XB is the concentration of the blocking drug, tubocurarine. And, when the slow component is very much slower than the fast one, as in the present case, we 270 ACTIONS OF TUBOCURARINE would expect T 1 k*B (6) as long as the concentrations of agonist and antagonist are so small that r-1 does not depend detectably on them.
In so far as these (rather drastic) approximations hold good, (a) the slope of the graph of f1 against XB (e.g. Fig. 11 ) can be interpreted as an estimate of k+B, and in this way are plotted against membrane potential in Fig. 15 . It can be seen that (a) very similar values were found, whether Tr was estimated from voltage-jump relaxations, or from noise measurements, and (b) the channel blocking rate constant (unlike the inferred receptor block) increases quite sharply as the end-plate is hyperpolarized. The potential dependence appears to be exponential (Fig. 15 ) so it can be written
where k*B(O) = O*24 x 17 M-1 sec-'), and HB+i the increment in membrane potential that produces an e-fold increase in k-B, is -62 + 8 mV (from pooled results). Thus, at -80 mV, k*B is estimated to be about 0 9 x 107 M1 sec1, and at -150 mV k+B is about 2 7 x 107 M-1 sec-. Even if the theory were correct, there would be 271 D. COLQUHOUN, F. DREYER AND R. E. SHERIDAN several sources of error in these estimates; some of these are considered in the Discussion.
The rate constant for unblocking of channels, k*B in scheme 4, also appears to be voltage dependent, though in the opposite direction to k* B as might be expected. In Fig. 13 , 7-1 is not strongly dependent on the concentrations of tubocurarine and carbachol, so eqn. (6) may be used as a rough approximation. This gives (see Fig. 13 ) estimates of k*B = 0-86 + 0*03 sec-1 at -70 mV, and 0*32 sec-' at -120 mV. However, there does appear to be some dependence on tubocurarine concentration in Fig. 13 , and Fig. 14 shows a strong dependence of -r-1 on agonist concentration when the latter is increased sufficiently. Therefore an improvement on the approximation in eqn. (6) 
In this equation, N is the total number of ion channels, y is the conductance of a single open channel, Vrev is the reversal potential, and P is the hypothetical current that would have been observed to flow at equilibrium (with concentrations XA and XB of agonist and antagonist) if the antagonist were a purely competitive blocker (no ion channel block). In those experiments with the most complete results it was possible to estimate all of the quantities needed to use eqn. (11). The value of I can, for example, be read from the dashed lines in Fig. 2 (though in some cases this may involve rather dubious extrapolation of the observed concentrationresponse relationship). An example of this sort of analysis is shown in Fig. 16 While this calculation can hardly be regarded as a precise method of estimating the number of ion channels at the end-plate, it is rather close to the value that would be expected from existing knowledge. Dreyer, Peper & Sterz (1978) estimate that carbachol can open, at most, about 8000 channels per jsm of terminal; and Dionne, Steinbach & Stevens (1978) estimate that carbachol can open, at most, about half of all channels. Therefore a 500 ,um terminal would have about 0-8 x 107 channels (rather less than the number of BuTX binding sites which is 3-4 x 107 per end-plate; Barnard, Chiu, Jedrzejcyjk, Porter & Wiechowski, 1973; Matthews-Bellinger & Salpeter, 1978) . This agreement must be regarded as evidence in favour of a mechanism of the general type summarized in scheme (4).
The slope of the line at -70 mV in Fig. 16 should be lower in proportion to the value of kI+B; the slope drawn in Fig. 16 is that predicted from the observed values of kB at -70 mV and at -120 mV (together with the observed slope at -120 mV).
The predicted slope at -70 mV is so shallow that it is not surprising that it cannot be estimated from the observations.
Only three experiments were sufficiently complete for the analysis shown in Fig.  16 to be done with reasonable precision. These experiments gave estimates of k*CB of 0-92 sec-' at -70 mV, 1.0 sec-1 at -80 mV, 0-46 sec-1 at -100 mV and 0 34, Eqn. (8) also predicts that the slow rate constant, 8-r1, should rise linearly with agonist concentration at first, and then flatten off. This is not the shape of the observed curve (Fig. 14) . However, a shape of the general sort that is observed is actually expected, because of the cooperativity of the response, which has been neglected, for simplicity, in scheme 4. The reason for this expectation is roughly as follows (D. Colquhoun, in preparation) . If the response is small (as it is) the fraction of channels that would be opened if tubocurarine were purely competitive, pI say, Notice, that, apart from the factor s, this is simply the rate constant that would be expected for equilibration of binding to the open channel, viz. the sum of the dissociation rate, k*B, and the association rate p k+BXB. It would be expected that a factor such as p I would be involved because open channels are one of the reactants in the channel blocking reaction, and they make up a small fraction only of all channels. Now for non-cooperative reaction schemes, like scheme 4, pt will be hyperbolically related to agonist concentration. But in fact there is cooperativity and pt is actually related in a sigmoid manner to agonist concentration. The flat region at low agonist concentration, preceding the rise in r-1 at higher agonist concentrations (Fig. 14) is, therefore, to be expected.
The equilibrium constant for binding to open channels. According to the interpretation of the observations in terms of scheme 4, it is found that the rate constant for ion channel blocking, k+B, increases with hyperpolarization, and that for unblocking, k*B, decreases to a similar (but less certain) extent. Therefore the equilibrium con- 
DISCUSSION
The evidence in favour of various possible mechanisms for the actions of tubocurarine has been discussed in the Results section. There are, however, a number of potentially serious sources of error in both (a) our experimental methods and (b) our interpretation of observations even in the absence of technical errors. These will now be discussed.
Technical sources of error
Voltage clamp quality. The frog end-plate is so long that when it is all activated, as in the present experiments, the quality of voltage control at parts of the endplate most distant from the electrodes must be dubious. Furthermore, the considerable currents that flow during jumps to hyperpolarized potentials must, to some extent, result in a potential drop across any resistance in series with the end-plate membrane (e.g. the narrow synaptic cleft) so that the imposed potential is not, as assumed, all dropped across the end-plate membrane.
The main evidence that poor clamp quality has not seriously affected our results Anderson & Stevens, 1973) . The reversal potential of near zero is also in agreement with such experiments Colquhoun et al. 1975; Mallart et al. 1976; Katz & Miledi, 1977) . On the other hand, the time constant of about 2 msec that we observe for carbachol at -80 mV and about 8 0C is rather longer than the value of 0 9 msec reported by Dreyer, Walther & Peper (1976) for R. esculenta at -65 to -85 mV and 8-11 'C. If our value were genuninely longer, one reason could be imperfect voltage control. The possibility of electrode polarization has already been mentioned in the Methods section.
Desensitization. It is clear that desensitization (as shown in Fig. 1) will affect, to some extent, estimates of (a) the size of equilibrium responses and (b) the rate of the slow relaxations. Evidence has been presented that suggests that the latter effect is not very large. But desensitization may well account for part of the nonparallelism of the dose-response curves (e.g. Fig. 2) . In fact the ion channel block mechanism predicts a rather smaller degree of non-parallelism than that shown in Non-exponential control relaxations. In the presence of agonist, but no antagonist,
we have found that relaxations following voltage jumps usually contain a second, relatively slow, component as well as the main exponential relaxation. During brief hyperpolarizing jumps this appears as a sloping base line and a similar phenomenon has been observed by other workers who have used this method in muscle (Neher & Sakmann, 1975; Adams, 1977a) : the mechanism is unknown. In the presence of anything but the smallest tubocurarine concentrations the 'sloping baseline effect' is not usually obvious, but it may, nevertheless, cause some distortion in our results. Errors consequent on the small volume of the synaptic cleft. At modest antagonist concentrations there must be at least fifty bound tubocurarine molecules for every molecule that is free in solution in the synaptic cleft (see Results). Molecules of tubocurarine, or of agonist, that are carried into the cleft by the clamp current may thus have a substantial effect on the drug concentration in the cleft. This problem has been considered in the Results and Appendix and the predicted effects of ionophoretic tubocurarine influx do not agree well with our observations: however the method of prediction is over-simplified, and the size of the predicted effects is not obviously negligible, so it cannot be ruled out that effects of this sort distort our observations, and hence their interpretation.
The small cleft volume also means that any change in the number of bound tubocurarine molecules would be expected to produce an exaggerated change in the concentration in solution in the synaptic cleft. This perturbed cleft concentration would then have to re-equilibrate more or less slowly by diffusional exchange with external bulk tubocurarine solution: this process might distort the rates of changes in end-plate current that are observed. The ion channel block mechanism predicts only small changes in antagonist binding during the fast relaxations following voltage jumps, but substantial slow changes in tubocurarine binding are predicted. After a hyperpolarizing jump a considerable increase in the fraction of blocked channels (state ARB in scheme 4) is predicted. But if, as in scheme 4, there is also Block of open ion channels was first suggested (for ganglionic synapses) by Blackman (1959 Blackman ( , 1970 and Blackman & Purves (1968) . And evidence that quaternary local anaesthetics work in this way at the muscle end-plate was presented Steinbach (1968a, b) . More recently it has been found that tubocurarine and hexamethonium, as well as procaine, seem to work primarily by block of open ion channels at Aplysia synapses (Marty et al. 1976; Ascher et al. 1978; Marty, 1978) , and that a similar mechanism describes the action at the neuromuscular junction of (a) barbiturates (Adams, 1976b) , (b) various local anaesthetics (Kordas, 1970; Katz & Miledi, 1975; Beam, 1976; Adams, 1977b; Ruff, 1977; Neher & Steinbach, 1978) , (c) the partial agonist, decamethonium (Adams & Sakmann, 1978) and, perhaps, other agonists (Colquhoun et al. 1975) , (d) atropine (Katz & Miledi, 1973b; Adler & Albuquerque, 1976; Feltz et al. 1977; Adler, Albuquerque & Lebeda, 1978) , (e) amantadine (Albuquerque, Eldefrawi, Eldefrawi, Mansour & Tsai, 1978) , and (f) prednisolone (Dreyer, Peper, Sterz, Bradley & Muller, 1979) .
Selective block of open ion channels alone will not adequately account for our observations with tubocurarine, but, as Manalis (1977) supposed in his work, a combination of this action with competitive block of the classical sort (Jenkinson, 1960) will describe most of our experimental results. We have recently found evidence for a similar, but faster (procaine-like) action of gallamine (Colquhoun & Sheridan, 1979) . Our conclusions concerning both tubocurarine and gallamine are consistent with those of Katz & Miledi (1978) , though they disagree (in the case of tubocurarine) with those of Albuquerque et al. (1978) .
Problems of interpretation. In addition to the general sources of error already discussed, there are other problems of interpretation that are particular to competitive plus channel block mechanisms such as that shown in scheme 4. Even if a mechanism of this sort were supposed to be correct, it would still be necessary to consider two factors that have been omitted so far, viz. the effects of lack of knowledge about (a) the rate of competitive block and (b) the details of the cooperative mechanism of agonist action. More details will be given elsewhere (D. Colquhoun, in preparation) .
It has already been mentioned that under a wide range of conditions it would be 277 expected that only two kinetic components would be large enough to be resolved experimentally. This will be true if the rate of equilibration of the antagonist with the acetylcholine binding site, considered in isolation, viz.
k+BXB + kl1B = klB(t + CB) for scheme 4 (Hill, 1909) , is either much faster, or much slower than the channel lifetime, a. If the equilibrium were much faster than a, the methods used to estimate channel blocking rates (k*/B and k*B) should be fairly accurate. If the equilibration were much slower than a, then they would be less accurate; in particular kl+B would probably be over-estimated. The observation that peak currents, which are attained with a rate constant of the order of a, behave in a way close to that expected for pure competitive block at equilibrium (see Fig. 3 ), suggests that the interaction of tubocurarine with the nicotinic receptor can reach equilibrium fairly rapidly (though this test is not a very critical one at lower tubocurarine concentrations). Numerical calculations show that the methods used to estimate the channel dissociation rate constant, k*B, do not depend critically on the competitive rate constants. And, at the tubocurarine concentrations that are not too low, reasonable estimates of k+B can be obtained if k-B is at least 100 sec-' (time constant for dissociation of tubocurarine from the acetylcholine binding site 10 msec or less). Since we estimate that KB = 0 34 ftM, this value implies that k+B must be at least 3 x 108 M-1 sec-'. However, over some concentration ranges these calculations suggest that even a value of k-B as slow as 10 sec-1 (time constant for TC dissociation of 100 msec, and k+B = 3 x 107 M-1 sec-') might allow tolerable k*B estimates. The experiments of Armstrong & Lester (1979) suggest that the dissociation time constant kz1, must be at most 100 msec, and other, much more indirect, estimates suggest that equilibration of tubocurarine with the acetylcholine receptor may be faster than this, with kI1 = 1-40 msec (Ferry & Marshall, 1973; Blackman, Gauldie & Milne, 1975 , and, in electric eel, Sheridan & Lester, 1977 .
The arguments in the preceding paragraph all remain true for a variety of mechanisms which take into account the cooperativity of the agonist response (neglected in scheme 4). Further details will be given by D. Colquhoun (in preparation).
There is one prediction of scheme 4, and of related but cooperative mechanisms, that we have not observed. It is predicted that under certain conditions both the fast and slow relaxation that follow a depolarizing voltage jump may be opposite in direction to the relaxations that were usually observed (e.g. in the right-hand section of Fig. 5B ). The predictions are as follows. (a) The fast relaxation should, at rather high antagonist concentrations, become inverted (i.e. represent a net opening of channels). We have observed this phenomenon under conditions similar to those for which it is predicted. (b) The slow relaxation should, at low agonist concentrations, reverse its normal direction (i.e. it should represent a net shutting of channels). We have never unambiguously observed this phenomenon, though at low agonist concentration virtually no slow relaxation can be seen. This may be because we have not been able to use sufficiently low agonist concentrations; in any case it does not seem to be a sufficiently large difference between prediction and experiment to rule out mechanisms of the type of scheme 4.
ACTIONS OF TUBOCURARINE
Can tubocurarine fit into an ion channel? The simplest interpretation of ion channel blockage is to suppose that tubocurarine can be inserted into, and hence plug, the ion channel. Crystallographic studies (Sobell, Sakore, Tavale, Canepa, Pauling & Petcher, 1972; Codding & James, 1973; Reynolds & Palmer, 1976) show that the molecule has a substantial degree of flexibility, and that the six rings do not all lie in the same plane. It can adopt a curved conformation with a convex surface that is largely hydrophilic and a concave surface that is almost entirely hydrophobic. Not enough is known about the structure of the ion channel for any judgment to be made, at the moment, about whether or not the charged group (or groups) of such a structure could be inserted into the mouth of the channel. But the mouth of the channel may be quite wide; some fairly large molecules can enter, and even penetrate, the channel (see, for example, Furukawa & Furakawa, 1959; Nastuk, 1959; Creese & Maclagan, 1970; Adams & Sakmann, 1978;  and the references to local anaesthetic actions above). The voltage dependence of the 'channel block' equilibrium constant is inferred to be roughly 30 mV for an e-fold change. This parameter should be estimated by RT/z6F (e.g. Woodhull, 1973) where a is the fraction of the membrane field that acts on z charges. At 8 0C RT/F is about 24 mV, so to account for the observed voltage dependence, the tubocurarine molecule would have to sense about 80 % of of the membrane potential if only one charge were in the electric field, or about 40 % if both charges were in the field.
How important are the non-classical actions of tubocurarine? In view of the strong voltage dependence of the putative channel blocking component of the action of tubocurarine, it is most unlikely that it contributes appreciably to the block of single nerve-evoked end-plate potentials. However, the rate constants that apply to mammalian muscle at 37 0C are quite unknown, and it is possible that channel block, which is characteristically 'use-dependent', may contribute (along with decrease in transmitter release) to the deepening of paralysis that is often observed during high frequency stimulation in the presence of 'competitive' neuromuscular blocking agents (see, for example, Waud & Waud, 1971; Bowman & Webb, 1976) . D. COLQUHOUN, F. DREYER AND R. E. SHERIDAN In this equation, I is the current (inward current taken as negative), co is the normalized concentration of antagonist in the solution (i.e. molar concentration divided by K), K is the equilibrium dissociation constant for the antagonist, z is its charge (taken as 2 at the pH of our experiments), pr is the fraction of free sites (those not occupied by antagonist), M is the number of moles of binding site in the cleft and V is the volume of the cleft. This is the same as eqn. (2) of Colquhoun & Ritchie (1972) except for the addition of a term for the ionophoretic flux. In the calculations, the current, I, is taken to be the net drug-induced current, i.e. it is assumed that all of this current, but none of the remainder of the clamp current, flows into the synaptic cleft. If we take jp = 1/(1 + ci), i.e. the effect of the agonist (which is present in low concentration) on antagonist binding is neglected, then, when the current, I, is constant the solution of this equation is exactly the same as given in Colquhoun & Ritchie (1972) , as long as the appropriate equilibrium value for pr is used. When the current, I, is constant this is pr(oO)) =1 + co(1 + I/0.124zFVkc)* (A 2) For small perturbations in pf, the approach to equilibrium will be nearly exponential, (Dreyer, Peper & Sterz, 1978 and, in electric eel, Sheridan & Lester, 1977) , then (1+M/KV) is about 124 for tubocurarine and 2-2 for acetylcholine. These are the factors by which binding is expected to slow down the diffusion rate (with low ligand concentration and rapid binding), and they are the sort of values that would be expected on the basis of present knowledge (Katz & Miledi, 1973 a; Magleby & Terrar, 1975; Colquhoun et al. 1977; Sheridan & Lester, 1977; Armstrong & Lester, 1979) .
However, in the case of tubocurarine, we have neglected the fact that the ionophoretic influx of tubocurarine into the cleft is expected to reduce the current that causes the influx. An approximate allowance for this can be made if we suppose that the current is given, at time t, by 1(t) -NyEc~pr(t)/Kc, (A 4) where N is the number of channels, y is the single channel conductance, E is the membrane potential (reversal potential taken as zero, as before), CA is the normalized agonist concentration (assumed constant), n is the low-concentration Hill coefficient and Kc = a/l,8 is the equilibrium constant for opening of the ion channel. Eqn.
(A 4) should apply, as an approximation, to a wide range of mechanisms for channel 280
